Prize4Life
| Formation | June 2007 |
|---|---|
| Founder | Avi Kremer |
| Type | Non-profit |
| Location(s) |
|
| Website | Prize4Life Prize4Life Israel |
Prize4Life is a non-profit organization dedicated to the discovery of treatments and a cure for amyotrophic lateral sclerosis (ALS). The organization uses the inducement prize contest model. It was founded in 2007 by Avi Kremer, an Israeli student at Harvard Business School, who was diagnosed with ALS at the age of 29.[1]
On February 3, 2011, Prize4Life announced the award of their first prize, the $1M ALS Biomarker Prize, to Seward Rutkove for his development of a tool to track the progression of the disease.[1]
On November 1, 2018, Prize4Life in the United States announced they were shutting down and transferring their assets to the ALS Association.[2] The Israeli nonprofit under the same name continues to operate.[citation needed]
References
- ^ a b $1 Million to Inventor of Tracker for A.L.S., The New York Times, February 8, 2011
- ^ "Avi Kremeunder of Prize4Life, Joins The ALS Association Team". ALSA.org. Retrieved November 29, 2018.
Further reading
- Venkataraman, Bina (2011-02-08). "$1Million to Inventor of Tracker for A.L.S". The New York Times
- Dance, Amber (2009-04-30). "News Brief: Scientists Net Prizes for Progress Toward ALS Biomarker". Alzheimer Research Forum. Retrieved 2009-05-11.
- Begley, Sharon (2008-10-21). "Help Mouse with Lou Gehrig's Disease. Win $1 Million". Newsweek Lab Notes. Retrieved 2009-05-11.
- Shnabel, Jim (2008-08-07. "Standard Model". Nature News. Retrieved 2009-05-11.
- Travis, John (2008-03-28). "Science by the Masses". Science Magazine. Retrieved 2009-05-11.
- Smith, Stephen (2007-05-28). "The Business of Survival". The Boston Globe. Retrieved 2009-05-11.
- Thayer, Ann (2006-11-15). "Big Biomarker Prize". Chemical and Engineering News. Retrieved 2009-05-11.
- Wessel, David (2006-06-23). "Using M.B.A. Drive To Speed an ALS Cure". College Journal. Retrieved 2009-05-11.
External links
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.